- Report
- January 2022
- 68 Pages
Europe
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 78 Pages
Asia Pacific
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 90 Pages
Asia Pacific
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 111 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 112 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 121 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 110 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 115 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 121 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 120 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 114 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- January 2022
- 115 Pages
Global
From €4578EUR$4,750USD£3,805GBP
- Report
- August 2020
- 115 Pages
Global
From €4096EUR$4,250USD£3,404GBP
- Report
- August 2020
- 114 Pages
Global
From €4096EUR$4,250USD£3,404GBP
- Report
- September 2023
- 112 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Report
- August 2023
- 135 Pages
Global
From €7229EUR$7,500USD£6,008GBP
- Report
- August 2023
- 66 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Report
- July 2023
- 243 Pages
Global
From €7229EUR$7,500USD£6,008GBP
- Report
- July 2023
- 68 Pages
Global
From €3807EUR$3,950USD£3,164GBP
- Report
- June 2023
- 245 Pages
Global
From €7229EUR$7,500USD£6,008GBP
The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy.
The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more